Apricitabine News and Research

RSS
Avexa halts HIV drug trials

Avexa halts HIV drug trials

Avexa's ATC Phase III study concludes

Avexa's ATC Phase III study concludes

Shire licenses the north American rights for Apricitabine to Avexa

Shire licenses the north American rights for Apricitabine to Avexa